Mono-(2-ethyl-5-oxohexyl) Phthalate Test

Mono-(2-ethyl-5-oxohexyl) phthalate is a secondary oxidative metabolite of di(2-ethylhexyl) phthalate. Unlike mono-2-ethylhexyl phthalate, which is formed early in DEHP metabolism, this compound reflects further processing in the liver through oxidative pathways. As a result, it can provide additional insight into both exposure burden and how the body is handling detoxification.

This metabolite is particularly useful because it is less susceptible to external contamination and more stable in urine, making it a reliable indicator of true internal exposure. Elevated levels point to meaningful contact with DEHP from sources such as packaged foods, plastic storage containers, medical devices, and household materials. Because DEHP exposure is often continuous and low dose, secondary metabolites like this one help capture longer lasting biological impact.

From a physiological standpoint, mono-(2-ethyl-5-oxohexyl) phthalate is associated with hormone disruption, altered lipid signaling, and inflammatory activation. Disruption of lipid signaling can impair how cells respond to insulin and manage fat storage, which helps explain observed links to obesity, fatty liver disease, and cardiovascular risk. These effects are especially relevant for individuals focused on long term metabolic resilience and healthy aging.

That said, levels may vary based on liver enzyme activity, particularly cytochrome P450 systems involved in phase I detoxification. This means that differences in genetics, nutrition, and overall liver health can influence measured concentrations. Interpreting this marker alongside other phthalate metabolites provides a more complete picture than any single value alone.